A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy.

[1]  M. Calsolari,et al.  Determination of the antioxidant status of plasma from type 2 diabetic patients. , 2007, Diabetes research and clinical practice.

[2]  M. Murakami,et al.  Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. , 2006, Molecular biology of the cell.

[3]  J. Suh,et al.  Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. , 2006, Biomaterials.

[4]  R. Cristiano,et al.  Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate , 2006, Gene Therapy.

[5]  Jun Yao,et al.  Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. , 2006, Cancer research.

[6]  I. Alferiev,et al.  Site specific gene delivery in the cardiovascular system. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[7]  In-Kyu Park,et al.  Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  A. Göpferich,et al.  Polyethylenimine-based non-viral gene delivery systems. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  J. Behr,et al.  Polyethylenimine (PEI). , 2005, Advances in genetics.

[10]  J. Aigueperse,et al.  In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery , 2004, Genetic vaccines and therapy.

[11]  R. Stocker,et al.  Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 , 2004, Circulation.

[12]  A. Gupta,et al.  Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[13]  N. Ueno,et al.  Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[14]  C. Lamers,et al.  A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients , 2004, British Journal of Cancer.

[15]  Y. Ohya,et al.  Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[16]  R. Kok,et al.  A nonviral carrier for targeted gene delivery to tumor cells , 2004, Cancer Gene Therapy.

[17]  鈴木 正崇.  Recombinant single-chain antibodies with various oligopeptide tails for targeted gene delivery , 2004 .

[18]  W. Jongmans,et al.  Targeting of adenovirus to human renal cell carcinoma cells. , 2003, Urology.

[19]  J. Kopeček,et al.  Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.

[20]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[21]  J. Xiong,et al.  Expression of hepatitis B virus X protein in transgenic mice. , 2003, World journal of gastroenterology.

[22]  J. Schalken,et al.  Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies. , 2002, Urology.

[23]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[24]  Y. Tan,et al.  Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[25]  B. Kinsey,et al.  Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  C. Leamon,et al.  Folate copolymer-mediated transfection of cultured cells. , 1999, Bioconjugate chemistry.

[27]  A. Dürrbach,et al.  Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro , 1999, Cancer Gene Therapy.

[28]  S. Saga,et al.  MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas , 1999, British Journal of Cancer.

[29]  J. Behr,et al.  Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway , 1999, Gene Therapy.

[30]  D. Blakey,et al.  Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. , 1987, Journal of the National Cancer Institute.

[31]  D. Ruiter,et al.  Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney , 1986, International journal of cancer.

[32]  H. Friesen,et al.  A monoclonal antibody to the growth hormone receptor of rabbit liver membranes. , 1983, Endocrinology.

[33]  P. Keng,et al.  Inhibition of cell growth in synchronous human hypernephroma cells by recombinant interferon alpha-D and irradiation. , 1983, Journal of interferon research.